Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats.
Prostaglandin E2 receptor EP4 is involved in inflammation and related tumorigenesis in the colorectum. This study aimed to investigate the chemopreventive ability of RQ-15986, a selective EP4 antagonist, in colitis-related colorectal tumorigenesis. Male Kyoto APC delta rats, which have APC mutations...
Enregistré dans:
Auteurs principaux: | Yohei Shirakami, Takayuki Nakanishi, Noritaka Ozawa, Takayasu Ideta, Takahiro Kochi, Masaya Kubota, Hiroyasu Sakai, Takashi Ibuka, Takuji Tanaka, Masahito Shimizu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/632ca27268e34ffbae3aa9cd0de6aa1e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
- RQ
-
Novel FXR agonist nelumal A suppresses colitis and inflammation-related colorectal carcinogenesis
par: Tsuneyuki Miyazaki, et autres
Publié: (2021) -
Apc mutation enhances PyMT-induced mammary tumorigenesis.
par: Jenifer R Prosperi, et autres
Publié: (2011) -
Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
par: Zhengxiang He, et autres
Publié: (2017) -
Interplay between c-Src and the APC/C co-activator Cdh1 regulates mammary tumorigenesis
par: Tao Han, et autres
Publié: (2019)